Evidence map›Paper›PMID 25485836›Full record

ArticleNature genetics2015

A conditional piggyBac transposition system for genetic screening in mice identifies oncogenic networks in pancreatic cancer.

Roland Rad, Lena Rad, Wei Wang, Alexander Strong, Hannes Ponstingl, Iraad F Bronner, Matthew Mayho, Katja Steiger, Julia Weber, Maren Hieber and 35 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. eLife · 2023
    Article
  10. Review
  11. Article
  12. Cell genomics · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Oncology reports · 2021
    Observational
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

45 authors at 12 institutions in 5 countries.

Roland Rad1] Department of Medicine II, Klinikum Rechts der Isar, Technische Universität München, München, Germany. [2] German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. [3] The Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire, UK.
Lena RadThe Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire, UK.
Wei WangThe Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire, UK.
Alexander StrongThe Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire, UK.
Hannes PonstinglThe Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire, UK.
Iraad F BronnerThe Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire, UK.
Matthew MayhoThe Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire, UK.
Katja SteigerDepartment of Pathology, Klinikum Rechts der Isar, Technische Universität München, München, Germany.
Julia Weber1] Department of Medicine II, Klinikum Rechts der Isar, Technische Universität München, München, Germany. [2] German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Maren HieberDepartment of Medicine II, Klinikum Rechts der Isar, Technische Universität München, München, Germany.
Christian VeltkampDepartment of Medicine II, Klinikum Rechts der Isar, Technische Universität München, München, Germany.
Stefan EserDepartment of Medicine II, Klinikum Rechts der Isar, Technische Universität München, München, Germany.
Ulf Geumann1] Department of Medicine II, Klinikum Rechts der Isar, Technische Universität München, München, Germany. [2] German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Rupert ÖllingerDepartment of Medicine II, Klinikum Rechts der Isar, Technische Universität München, München, Germany.
Magdalena ZukowskaDepartment of Medicine II, Klinikum Rechts der Isar, Technische Universität München, München, Germany.
Maxim Barenboim1] Department of Medicine II, Klinikum Rechts der Isar, Technische Universität München, München, Germany. [2] German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Roman Maresch1] Department of Medicine II, Klinikum Rechts der Isar, Technische Universität München, München, Germany. [2] German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Juan CadiñanosInstituto de Medicina Oncológica y Molecular de Asturias (IMOMA), Oviedo, Spain.
Mathias FriedrichThe Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire, UK.
Ignacio VarelaInstituto de Biomedicina y Biotecnología de Cantabria (UC-CSIC-SODERCAN), Santander, Spain.
Fernando Constantino-CasasDepartment of Veterinary Medicine, University of Cambridge, Cambridge, UK.
Aaron SarverBiostatistics and Bioinformatics Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA.
Jelle Ten HoeveBioinformatics and Statistics, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Haydn ProsserThe Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire, UK.
Barbara SeidlerDepartment of Medicine II, Klinikum Rechts der Isar, Technische Universität München, München, Germany.
Judith BauerInstitute of Virology, Technische Universität München, Munich, Germany.
Mathias HeikenwälderInstitute of Virology, Technische Universität München, Munich, Germany.
Emmanouil MetzakopianThe Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire, UK.
Anne KrugDepartment of Medicine II, Klinikum Rechts der Isar, Technische Universität München, München, Germany.
Ursula EhmerDepartment of Medicine II, Klinikum Rechts der Isar, Technische Universität München, München, Germany.
Günter SchneiderDepartment of Medicine II, Klinikum Rechts der Isar, Technische Universität München, München, Germany.
Thomas KnöselInstitute of Pathology, Ludwig Maximilians Universität München, München, Germany.
Petra RümmeleInstitute of Pathology, Universität Regensburg, Regensburg, Germany.
Daniela AustInstitute of Pathology, Technische Universität Dresden, Dresden, Germany.
Robert GrützmannDepartment of Surgery, Technische Universität Dresden, Dresden, Germany.
Christian PilarskyDepartment of Surgery, Technische Universität Dresden, Dresden, Germany.
Zemin NingThe Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire, UK.
Lodewyk WesselsBioinformatics and Statistics, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Roland M SchmidDepartment of Medicine II, Klinikum Rechts der Isar, Technische Universität München, München, Germany.
Michael A QuailThe Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire, UK.
George VassiliouThe Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire, UK.
Irene EspositoInstitute of Pathology, Medizinische Universität Insbruck, Insbruck, Austria.
Pentao LiuThe Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire, UK.
Dieter Saur1] Department of Medicine II, Klinikum Rechts der Isar, Technische Universität München, München, Germany. [2] German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Allan BradleyThe Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire, UK.
Wellcome Sanger Institute · GBKlinikum rechts der Isar · DETechnical University of Munich · DEHeidelberg University · DETU Dresden · DEThe Netherlands Cancer Institute · NLInstituto de Biomedicina y Biotecnología de Cantabria · ESInstituto de Medicina Genómica · ESLudwig-Maximilians-Universität München · DEUniversity of Cambridge · GBUniversity of Minnesota · USUniversity of Regensburg · DE

Funding

Wellcome Trust 095663
6 · The paper itself

Abstract

Here we describe a conditional piggyBac transposition system in mice and report the discovery of large sets of new cancer genes through a pancreatic insertional mutagenesis screen. We identify Foxp1 as an oncogenic transcription factor that drives pancreatic cancer invasion and spread in a mouse model and correlates with lymph node metastasis in human patients with pancreatic cancer. The propensity of piggyBac for open chromatin also enabled genome-wide screening for cancer-relevant noncoding DNA, which pinpointed a Cdkn2a cis-regulatory region. Histologically, we observed different tumor subentities and discovered associated genetic events, including Fign insertions in hepatoid pancreatic cancer. Our studies demonstrate the power of genetic screening to discover cancer drivers that are difficult to identify by other approaches to cancer genome analysis, such as downstream targets of commonly mutated human cancer genes. These piggyBac resources are universally applicable in any tissue context and provide unique experimental access to the genetic complexity of cancer.

Indexed as

Gene Regulatory NetworksMutagenesis, InsertionalAmino Acid SequenceAnimalsCell Transformation, NeoplasticDNA Transposable ElementsForkhead Transcription FactorsGene Expression ProfilingGene Expression RegulationGene Knock-In TechniquesGenes, p16Genes, SyntheticHumansMiceMice, TransgenicMolecular Sequence DataDNA Transposable ElementsForkhead Transcription FactorsFOXP1 protein, humanFoxp1 protein, mouseFoxp2 protein, mouseNeoplasm ProteinsProton-Translocating ATPasesRepressor ProteinsRNA, Small InterferingTransposases

Identifiers

PMID25485836
OpenAlexW2080812145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.